Zydus announces completion of Phase-I trials of ZY19489
ZY19489 has the potential to be a single-dose cure for P. falciparum and P. vivax malaria due to its novel mechanism of action,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.